-
MAPPING PATIENT-REPORTED OUTCOMES EVIDENCE REQUIREMENTS ACROSS GLOBAL MARKETS
Mar 18, 2026, 21:38 PM -
CLINICAL DEVELOPMENT LANDSCAPE AND CHARACTERISTICS OF RARE DISEASES IN THE U.S.
Mar 18, 2026, 21:38 PM -
AI-ENABLED RAPID GENERATION OF MULTI-COUNTRY PAYER AND REIMBURSEMENT LANDSCAPES FOR COLORECTAL CANCER
Mar 18, 2026, 21:38 PM -
UTILIZATION AND CLINICAL OUTCOMES OF DIRECT ORAL ANTICOAGULANTS IN REAL-WORLD SETTINGS: EVIDENCE FROM A GLOBAL FEDERATED RESEARCH NETWORK IN EUROPE
Mar 18, 2026, 21:38 PM -
THE SIMULATION MODEL FOR INTERVENTIONS LINKING EVIDENCE TO SOCIAL DETERMINANTS OF HEALTH (SMILES): A PLATFORM FOR EVALUATING THE LONG-TERM COST-EFFECTIVENESS OF LOCAL AND STATE POLICIES FOR CHRONIC DISEASE PREVENTION
Mar 18, 2026, 21:38 PM -
REAL-WORLD TREATMENT PATTERNS AND OUTCOMES IN US PLATINUM-RESISTANT OVARIAN CANCER PATIENTS: CHARACTERIZING THE UNMET CLINICAL NEED
Mar 18, 2026, 21:38 PM -
PSYCHOTROPIC MEDICATIONS USE AND HIP FRACTURE RISK IN COMMUNITY-DWELLING OLDER ADULTS: A NESTED KNOWLEDGE ASSISTED META-ANALYSIS
Mar 18, 2026, 21:38 PM -
AGENT-ATOM-GRADIENT: A NEXT-GEN AI ARCHITECTURE FOR EVIDENCE DRIVEN OUTCOMES RESEARCH
Mar 18, 2026, 21:38 PM -
IMPUTING MISSING DATA IN OBSERVATIONAL STUDIES: WHAT METHODS ARE BETTER?
Mar 18, 2026, 21:38 PM -
PORTABILITY OF PERFORMANCE STATUS CALCULATIONS IN REAL-WORLD CANCER CARE
Mar 18, 2026, 21:38 PM -
COST-CONSEQUENCE MODEL COMPARING ORIGINATOR R-HFSH-ALFA TO OTHER R-FSH-ALFA OPTIONS IN UP TO THREE COMPLETE OVARIAN STIMULATION CYCLES IN ASSISTED REPRODUCTIVE TECHNOLOGY IN CHINA
Mar 18, 2026, 21:38 PM -
INCORPORATING PUBLISHED SUBGROUP ANALYSES INTO MULTILEVEL NETWORK META-REGRESSION VIA BAYESIAN SYNTHETIC LIKELIHOOD
Mar 18, 2026, 21:38 PM -
SHEDDING LIGHT ON PATIENT-REPORTED OUTCOME MEASURE UTILIZATION ACROSS NSCLC THERAPIES
Mar 18, 2026, 21:38 PM -
TWO-YEAR COST ANALYSIS OF COMMON HEAD AND NECK CANCERS - INDEX PROCEDURES AND ADJUVANT THERAPIES
Mar 18, 2026, 21:38 PM -
SLEEP DISORDER DIAGNOSIS IN ADOLESCENCE AND SUBSEQUENT MENTAL HEALTH DIAGNOSES - A RETROSPECTIVE COHORT STUDY
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS ANALYSIS OF ACCESS TO THE FIRST OVER-THE-COUNTER ORAL CONTRACEPTIVE METHOD (OPILL) AMONG SEXUALLY ACTIVE ADULT WOMEN IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
SAFETY OF SEPIAPTERIN AND PEGVALIASE FOR THE TREATMENT OF PHENYLKETONURIA (PKU): A SIMULATED TREATMENT COMPARISON (STC)
Mar 18, 2026, 21:38 PM -
INCORPORATING REAL-WORLD EVIDENCE (RWE) USING A REAL-TIME AI-ASSISTED LIVING SYSTEMATIC LITERATURE REVIEW (REAL-SLR) AUGMENTS TRADITIONAL SLRS: CASE STUDY IN NON-SMALL-CELL LUNG CANCER (NSCLC)
Mar 18, 2026, 21:38 PM -
INTERPRETABLE MACHINE LEARNING TO PREDICT CATASTROPHIC HEALTH EXPENDITURE RISK IN CHINA: EVIDENCE FROM NATIONALLY REPRESENTATIVE SURVEY DATA
Mar 18, 2026, 21:38 PM -
COMPARATIVE ANALYSIS OF GENE THERAPIES AUTHORIZED BY THE U.S. FOOD AND DRUG ADMINISTRATION AND THE EUROPEAN MEDICINES AGENCY
Mar 18, 2026, 21:38 PM
